PALO ALTO, Calif. — November 25, 2025 — Leads & Copy —
BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that members of its management team will participate in fireside chats at the following healthcare investor conferences:
The Piper Sandler Healthcare Conference in New York, NY, will feature a fireside chat on Tuesday, December 2 at 10:30 a.m. EST.
The EvercoreISI HealthCONx Conference in Miami, FL, will hold a fireside chat on Wednesday, December 3 at 3:00 p.m. EST.
To access the live webcast of BridgeBio’s presentations, visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a biopharmaceutical company that discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015.
BridgeBio’s team of drug discoverers, developers, and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible.
BridgeBio Pharma, Inc. Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
(650)-789-8220
BridgeBio Pharma, Inc. Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
Source: BridgeBio Pharma, Inc.
